Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-152-8 | CAS number: 7440-43-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Epidemiological data
Administrative data
- Endpoint:
- epidemiological data
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1985-1989 (baseline CadmiBel) 1991-1994 (follow-up PheeCad)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- All selected studies were evaluated with a check-list relating to population, exposure, endpoints, biases and confounders. Used check-list are established by Professor Philippe Hotz from the Institut für Sozial- und Präventivmedizin der Universität Zürich (EU RA 2008).
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study
- Author:
- Hotz P , Buchet J P, Bernard A , Lison D and Lauwerys R
- Year:
- 1 999
- Bibliographic source:
- The Lancet 354: 1508-1513
Materials and methods
- Study type:
- cross sectional study
- Endpoint addressed:
- repeated dose toxicity: oral
- Principles of method if other than guideline:
- Study was conducted to assess whether environmental exposure to cadmium is associated with renal dysfunction.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Cadmium
- EC Number:
- 231-152-8
- EC Name:
- Cadmium
- Cas Number:
- 7440-43-9
- Molecular formula:
- Cd
- IUPAC Name:
- cadmium
- Details on test material:
- none
Constituent 1
Method
- Type of population:
- general
- Ethical approval:
- confirmed and informed consent free of coercion received
- Details on study design:
- STUDY POPULATION:
E: 1699 (M/F), age : 20-about 80 y
residents from two areas with low and two areas with high exposure to cadmiumto give a sufficiently large range of cadmium body burden in the
study population and to match the socio-economic environment of each polluted area with that of at least one less polluted area.
2327 were asked to participate, final population: 1699
- Exposure assessment:
- measured
- Details on exposure:
- U-Cd; 24-hr. Urinary samples
Geometric mean: 0.84/24h - Statistical methods:
- distributions were normalised by logarithmic transformation. Determinants affecting renal measurements were traced by stepwise regression.
Logistic model (relation between the frequency of abnormal values of the renal measurements and the internal dose of Cd assessed by its urinary excretion)
Results and discussion
- Results:
- -Association between tubular parameter and Cd-U : partial r² : 0.0684-0.0160
-After standardisation for several possible confounding factors, 5 variables (urinary excretion of beta-2µglobulin, RBP, NAG, amino-acids and calcium) were significantly associated with the urinary excretion of Cd (as a marker of Cd body burden), suggesting the presence of tubular dysfunction.
There was a 10% probability of values of these variables being abnormal when Cd excretion exceeded 2-4 µg/24h. Excretion reached this threshold
in 10% of non-smokers
-Dose - response curve : A positive association was found between Cd-U measured at baseline and the risk of fractures in women and possibly with a higher risk of height loss in men - Confounding factors:
- Taken into account and tested in the model :
age, gender, renal disease, diabetes, medication, BMI, urinary tract disease - Strengths and weaknesses:
- none
Any other information on results incl. tables
none
Applicant's summary and conclusion
- Conclusions:
- After adjustment for age, gender, smoking, use of medications and urinary tract disease, it was found that tubular effects (increased Ca-U) occurred
in the general population at Cd-U levels ≥ 2 µg/24 h (roughly equivalent to 2 µg/g creatinine). “Elevated” (> 95th percentile in the same cohort after
exclusion of individuals with renal disease, analgesic abuse and diabetes) urinary excretion of Ca, NAG, RBP, ß2M and amino acids was predicted with a probability of 10 % when the urinary excretion of cadmium reached 1.9, 2.7, 2.9, 3.1 and 4.3 µg/24 h, respectively - Executive summary:
In a cross-sectional population study to assess whether environmental exposure to cadmium is associated with renal dysfunction, 1699 subjects aged 20-80 years were studied as a random sample of four areas of Belgium with varying degrees of cadmium pollution. After standardisation for several possible confounding factors, five variables (urinary excretion of retinol-binding protein, N-acetyl-beta-glucosaminidase, beta 2-microglobulin, aminoacids, and calcium) were significantly associated with the urinary excretion of cadmium (as a marker of cadmium body burden), suggesting the presence of tubular dysfunction. There was a 10% probability of values of these variables being abnormal when cadmium excretion exceeded 2-4 micrograms/24 h. Excretion reached this threshold in 10% of non-smokers. There was also evidence that diabetic patients may be more susceptible to the toxic effect of cadmium on the renal proximal tubule.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.